Home | BioLizard

Who we work with

We support biotech, pharmaceutical and diagnostic companies, and research institutions of all sizes to enable truly data-driven discovery, preclinical, translational and clinical R&D processes. We also have robust experience working in the animal health field as well as in supporting food and agriculture R&D.

What we do

Leveraging our expertise in advanced bioinformatics, predictive analytics & AI, tailored software development, and data governance & architecture to support you in data-driven research and development and (pre)clinical studies.

Learn more →

How we do it

BioLizard brings together a diverse yet complementary range of expertises to implement the most up-to-date technological tools to meet your unique data needs, now and in the future. We believe that an inclusive and open communication strategy with our clients is essential for the successful completion of each project. We ensure to align regularly with you throughout the process, and adjust pipelines to best fit your unique data case and maximize your output.

When you partner with BioLizard, you get state-of-the-art data analysis pipelines and tools to apply to your current and future research projects - and moreover, you receive end-to-end support that will make it faster and easier for you to turn your data into actionable insights. We also always ensure to fully explain our data science approach to solving your biological challenges - there’s no black box when you work with BioLizard.

BioLizard Appoints Matthew Hall as Director of Business Development

We are pleased to announce the appointment of Matthew Hall, PhD, as Director of Business Development. Matthew's regional insights, gained from more than a decade as an insider in the Swiss biotech sector, combined with his expertise in AI and biology, make him a perfect fit for the BioLizard team. His unique profile and global network will further empower the company to expand and strengthen its presence in Switzerland and other key markets.

Read more →

Meet Jan Rommel at Anglonordic Life Science Conference 2024

Jan Rommel, Associate Project & Account Manager, is attending Anglonordic Life Science Conference from April 17th-18th.

Connect with Jan on LinkedIn →

Meet us at Amsterdam Chemistry Network's Chem Together #18

Volodimir Olexiouk, our Director of Scientific Engagement and AI & Analytics Team Lead, will speak at ACN's Chem Together #18 event with the focus: Unlocking AI-engineered medicines: from implementation to success.

Through practical strategies and real-life case studies, attendees will gain insights into accelerating drug discovery and optimizing operations with AI integration.

Register now →

BioLizard announces Swiss subsidiary

We are proud to announce that we have made an exciting new step in our continued international expansion, while deepening our commitment to our current and future Swiss partners and clients.

With the opening of our newest office at Biopôle Lausanne, we have officially entered the Swiss market. Biopôle, which houses 120 companies, provides the perfect conditions for us to engage with the Swiss biotech industry and offer our services exactly where our clients need them.

Read more →

BioLizard and AbnomX announce partnership

We are happy to announce our strategic partnership with AbnomX.

BioLizard’s custom advanced analytics services complement AbnomX’s innovative, user-friendly platform for deciphering immune repertoire data.

Read more →

BioLizard featured on Data Science Leaders podcast

Volodimir Olexiouk, our Director of Scientific Engagement and Data Science Team Lead, was featured in episode 70 of Domino Data Lab's Data Science Leaders podcast.

In this episode, host Kjell Carlsson speaks with Volodimir about best practices for overcoming the data challenges for AI-driven drug discovery and combining scientific expertise with data science for augmented intelligence in the life sciences.

Listen now →

Domino Data Science Leaders Podcast episode 70

BioLizard featured in Trends

BioLizard's role in heading digital transformation in the life sciences industry has been featured in the magazine Trends.

The article highlights BioLizard's proven expertise in supporting biotech and pharma with bioinformatics, data analytics, and leveraging of AI.

Read more →

BioLizard Highlighted at Bio-EUROPE

"It's not trivial to make sure that you have your data (management) right, to then be able to apply advanced analytics."

MC Services interviewed our BD Director Amparo Cuéllar at Bio-EUROPE. Check out the 2-minute video wherein she discusses:

The importance of ensuring that application of AI and other advanced analytics is grounded in an understanding of biology and your business strategy
Data analytics trends in the life sciences
What's next for BioLizard
Advice for companies who want to become more data-driven

Watch the 3-minute video →